Earnings Summary

Biogen Inc.’s revenue fell -7% since last year same period to $2290.5Mn in the Q1 2024. On a quarterly growth basis, Biogen Inc. has generated -4.01% fall in its revenue since last 3-months.

Biogen Inc.’s net profit jumped 1.42% since last year same period to $393.4Mn in the Q1 2024. On a quarterly growth basis, Biogen Inc. has generated 57.55% jump in its net profits since last 3-months.

Biogen Inc.’s net profit margin jumped 9.06% since last year same period to 17.18% in the Q1 2024. On a quarterly growth basis, Biogen Inc. has generated 64.14% jump in its net profit margins since last 3-months.

Biogen Inc.’s price-to-earnings ratio after this Q1 2024 earnings stands at 24.21.

Biogen Inc.’s earning per share (EPS) estimates for the current quarter stand at 3.44 - a 8.18% jump from last quarter’s estimates.

Biogen Inc.’s earning per share (EPS) estimates for the current year stand at 3.44.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Biogen Inc.’s return on assets (ROA) stands at 0.05.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Biogen Inc.’s return on equity (ROE) stands at 0.08.